SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-303222
Filing Date
2018-10-19
Accepted
2018-10-19 17:27:37
Documents
7
Period of Report
2018-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638268d8k.htm 8-K 20334
2 EX-1.1 d638268dex11.htm EX-1.1 148637
3 EX-5.1 d638268dex51.htm EX-5.1 7537
4 EX-99.1 d638268dex991.htm EX-99.1 8658
5 EX-99.2 d638268dex992.htm EX-99.2 8270
6 GRAPHIC g638268g07p83.jpg GRAPHIC 6140
7 GRAPHIC g638268g61m45.jpg GRAPHIC 3764
  Complete submission text file 0001193125-18-303222.txt   208554
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 181131118
SIC: 2836 Biological Products, (No Diagnostic Substances)